Source comparison
Ipamorelin Women Weight Loss Anti-Aging: Comparison Table
Mechanism GHSR-1a agonist. Selective GH release, minimal cortisol/prolactin elevation GHRH analog. Extends endogenous GH pulse duration GHRH analog. Stimulates natural GH release, short half-life Ghrelin mimetic. Long-acting oral GH secretagogue Ipamorelin off
This comparison does not assign a generated winner or score.
- Mechanism
- GHSR-1a agonist. Selective GH release, minimal cortisol/prolactin elevation
- GHRH analog. Extends endogenous GH pulse duration
- GHRH analog. Stimulates natural GH release, short half-life
- Ghrelin mimetic. Long-acting oral GH secretagogue
- Ipamorelin offers the cleanest side-effect profile for women due to receptor selectivity. No appetite surge, no cortisol spike
- Administration
- Subcutaneous injection, 1–2× daily
- Subcutaneous injection, 1–2× weekly (extended half-life)
- Subcutaneous injection, 1× daily before sleep
- Oral capsule, 1× daily
- Injectable peptides require reconstitution and cold storage; MK-677's oral convenience trades off against water retention risk
- Typical Female Dose
- 200–300 mcg per injection
- 1–2 mg per injection (weekly dosing)
- 200–500 mcg per injection
- 12.5–25 mg per day
- Lower doses in women reflect higher estrogen-mediated GH receptor sensitivity. Starting conservatively prevents side effects
- Fat Loss Effect
- Indirect via HSL activation. 0.5–1.0% body fat reduction per month with deficit
- Similar metabolic effect; longer half-life maintains stable GH elevation
- Comparable to ipamorelin but shorter duration of action
- Slightly stronger appetite stimulation may offset fat loss in some users
- All options require caloric deficit. The peptide creates favorable hormonal conditions but doesn't override thermodynamics
- Skin/Collagen Benefit
- Direct fibroblast stimulation. Measurable dermal thickness increase in 8–12 weeks
- Sustained GH elevation supports collagen synthesis over longer intervals
- Effective for collagen support but requires daily dosing consistency
- Oral bioavailability sufficient for anti-aging benefits; some report better sleep quality
- Ipamorelin and CJC-1295 show the most consistent dermatological improvements in research protocols
- Side Effect Profile
- Minimal. Occasional injection-site redness, transient water retention in first week
- Low. Rare reports of headache or dizziness at higher doses
- Well-tolerated; some users report flushing or lightheadedness
- Water retention and elevated fasting glucose in 15–20% of users at higher doses
- Ipamorelin's selectivity translates to fewer systemic disruptions. Best choice for women sensitive to cortisol or prolactin shifts
- Cost (Research Context)
- Moderate. $80–150 per 5 mg vial (10–25 doses depending on protocol)
- Higher. $120–200 per 2 mg vial (4–8 doses at typical female dosing)
- Moderate. $70–120 per 5 mg vial
- Lower. $50–80 per month (oral capsules, no reconstitution needed)
- Ipamorelin offers the best balance of efficacy, tolerability, and cost-per-dose for female-focused protocols